Earnings · China A-shares
Anhui Huaren Health Pharmaceutical Co., Ltd. Class A (301408) earnings
Anhui Huaren Health Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-26: net profit +37.53% year on year, +39.43% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -2.35% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-26
- Period end
- 2026-09-30
- Net profit YoY
- +37.53%
- Excl. one-offs YoY
- +39.43%
- Net profit QoQ
- +40.78%
- Result
- Good
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -1.85% | — |
| 3 days | -2.35% | — |
| 7 days | -0.28% | — |
| 14 days | -5.06% | — |
Report history
Over the last 8 reports, net profit grew year on year in 8 of them. The stock rose in the 3 trading days after 4 of 7 reports (average +1.26%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-27 | ¥215.54M | +37.53% | +39.43% | +10.85% | 0.54 | 9.86% | -2.35% | — | — |
| 2026 interim report | 2026-08-28 | ¥135.91M | +31.01% | +31.00% | +12.81% | 0.34 | 6.31% | -1.26% | -8.16% | +1.54% |
| 2026 Q1 report | 2026-04-25 | ¥79.34M | +29.60% | +30.49% | +12.17% | 0.20 | 3.71% | +6.01% | -21.16% | -20.86% |
| 2025 annual report | 2026-04-25 | ¥191.35M | +38.96% | +43.67% | +21.07% | 0.48 | 9.25% | +6.01% | -21.16% | -20.86% |
| 2025 Q3 report | 2025-10-25 | ¥156.73M | +45.21% | +51.00% | +19.06% | 0.39 | 7.62% | +1.44% | +27.11% | +27.33% |
| 2025 interim report | 2025-08-27 | ¥103.74M | +42.17% | +43.28% | +15.52% | 0.26 | 5.06% | -7.44% | -13.21% | -16.99% |
| 2025 Q1 report | 2025-04-29 | ¥61.22M | +28.15% | +31.11% | +14.71% | 0.15 | 3.01% | +7.51% | +13.25% | +10.67% |
| 2024 annual report | 2025-04-25 | ¥137.70M | +20.09% | +21.81% | +19.34% | 0.34 | 6.96% | +4.93% | +15.46% | +12.21% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.